United States: Supreme Court Lets Stand Court Of Appeals Ruling That Owner Of A Foreign Trademark May Sue Under The Lanham Act For Conduct In The United States

Last Updated: March 7 2017
Article by Paul C. Llewellyn and Kyle D. Gooch

In early March, the United States Supreme Court declined to hear an appeal in a significant trademark and unfair competition case decided in 2016 by the United States Court of Appeals for the Fourth Circuit, which addressed the territorial limits of trademark rights and the standing of a foreign trademark owner to assert claims based on conduct in the United States. The Fourth Circuit's decision held that the owner of a foreign trademark could assert claims against a US trademark owner under Sections 14(3) and 43(a) of the Lanham Act for false association, false advertising, and cancellation of a US trademark registration—even though the foreign trademark owner had never used its mark in United States commerce. Belmora LLC v. Bayer Consumer Care AG, 819 F.3d 697 (4th Cir. 2016), cert. denied, 2017 WL 737826 (U.S. Feb. 27, 2017).1


For several decades, Bayer Consumer Care AG has sold an over-the-counter analgesic in Mexico under the mark FLANAX. Although the product is popular in Mexico—it is the top-selling pain reliever in Mexico, according to Bayer's court filings—it has never been marketed or sold in the United States. A Bayer affiliate sells a product in the United States with the same active ingredient (naproxen sodium) under the brand name ALEVE.

In 2004, Belmora LLC began selling a FLANAX-branded product in the United States in packaging that was "virtually identical" to the packaging used by Bayer in Mexico for its FLANAX product, "including a similar color scheme, font size and typeface." There was also evidence that Belmora was deliberately marketing its product to suggest a connection between its FLANAX products in the US and Bayer's FLANAX product in Mexico. Belmora received a federal trademark registration for FLANAX in 2005.

The Trademark Registration Proceeding

Bayer filed a petition with the Trademark Trial and Appeal Board (TTAB) to cancel Belmora's mark on various grounds, including a claim for misrepresentation under Lanham Act Section 14(3). Although the TTAB dismissed certain of Bayer's claims (including one for likelihood of confusion with Bayer's Mexico-based mark), the TTAB held that Bayer had standing to pursue its Section 14(3) claim because it "has an interest in protecting its Mexican FLANAX mark." Because "the reputation of the Mexican FLANAX mark does not stop at the Mexican border," Belmora's actions meant that Bayer would lose control over its reputation and, as a result, would suffer damage sufficient to confer standing. The TTAB also held in favor of Bayer on the merits of the Section 14(3) claim and ordered Belmora's mark to be canceled.

The District Court's Decision

Belmora sought review of the TTAB's cancellation decision in federal district court. The action was consolidated with a separate suit filed by Bayer, which alleged claims for false advertising and false designation of origin under Section 43(a) of the Lanham Act. Belmora moved to dismiss Bayer's claims and sought judgment on the pleadings on its appeal from the TTAB cancellation proceeding.

The district court applied the "zone of interests" test for Lanham Act standing established by the Supreme Court in Lexmark Int'l v. Static Control Components, Inc., 134 S. Ct. 1377 (2014). The district court concluded that Bayer was not within the zone of interests that Congress intended to protect because (relying on the principle that trademarks are territorial) Bayer had no legal interest in the FLANAX mark in the US. In addition, the district court held that any reputational injury suffered by Bayer was not proximately caused by Belmora's actions, because Bayer did not plead facts sufficient to show that it has a protectable interest in a US mark. Given Bayer's lack of standing, the district court dismissed Bayer's Lanham Act claims and reversed the TTAB's decision to cancel Belmora's mark.

The Fourth Circuit's Decision

On appeal, the Fourth Circuit reached the opposite conclusion. The court noted that while Lanham Act Section 32 expressly required that a claim be brought by the owner of a registered mark, Section 43(a) contained no such limitation. The court also noted that the ownership of a valid mark has not been viewed as a prerequisite to suits for unfair competition, citing cases where parties whose own marks became generic were held to have standing to challenge usages that created confusion as to the source of the defendant's product. See, e.g., Kellogg Co. v. Nat'l Biscuit Co., 305 U.S. 111 (1938).

As did the district court, the Fourth Circuit looked to the zone of interests test established by Lexmark to determine whether Bayer could assert its Lanham Act claims. The court concluded that Bayer's allegation that it was losing sales revenue in Mexico as a result of Belmora's alleged deceptive and misleading use of the FLANAX mark in the US was sufficient to put it within the zone of interests protected by Section 43(a) of the Lanham Act, as was the allegation of a Bayer affiliate (also a party to the action) that it was losing sales of ALEVE in the United States. The court similarly held that Bayer fell within the zone of interests protected by Section 14(3) of the Lanham Act because that provision generally seeks to prohibit the same type of conduct—deceptive and misleading use of a mark—as Section 43(a)'s false association prong.

The Supreme Court Declines to Hear the Case

In October 2016, Belmora filed a petition for a writ of certiorari, arguing that the decision abrogated the longstanding principal that trademark rights are territorial in nature. Belmora also argued that the decision deepened a pre-Lexmark split among the circuits as to whether entities that own famous foreign trademarks may assert trademark rights in the United States. Bayer opposed the petition, arguing that there was no circuit split and that the Fourth Circuit's opinion was the first post-Lexmark court to address the issue of whether use of a mark in US commerce is a prerequisite to a suit under the Lanham Act. On February 27, 2017, the Supreme Court denied Belmora's petition without comment. As a result, the Fourth Circuit's decision remains good law, and owners of foreign trademarks can argue that their foreign trademark rights provide standing to assert at least some claims under the Lanham Act, including claims to cancel registrations of marks that are deceptive and misleading, and claims for false advertising and unfair competition arising from the use in the US of a mark confusingly similar to a foreign mark. 


1 Arnold & Porter Kaye Scholer represents certain corporate affiliates of Bayer Consumer Care AG on other matters, but was not involved in the litigation discussed in this alert.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions